06–08 October 2026
Fiera Milano, Italy
For more than three decades, we have developed and manufactured APIs for pharmaceutical companies worldwide. Our integrated manufacturing operations give us greater control over quality, cost, and supply across the value chain.
Our growing portfolio spans a wide range of therapeutic categories, including pain management, antidiabetic, cardiovascular, central nervous system, and anti-ulcer APIs. Strong R&D capabilities, robust quality systems and large-scale manufacturing enable us to meet the evolving needs of global pharma.
At IOLCP, we believe dependable supply begins with strong capabilities and is strengthened through lasting partnerships. That is why we remain focused on consistent quality, responsive support, and delivering on our commitments.
Learn MoreCPHI Milan brings together leading companies, innovators, and professionals from the global pharmaceutical supply chain. The event provides a valuable platform to explore emerging solutions, discover new capabilities, and connect with potential partners from across the industry.
Through face-to-face meetings, expert-led discussions, and collaborative opportunities, attendees can exchange ideas, gain valuable industry insights, and build relationships that support long-term business growth.
Beyond the event, CPHI’s year-round online platform helps pharma professionals stay connected with companies, products, and industry insights from around the globe.
IOLCP combines manufacturing expertise, scientific capability, and a deep understanding of customer needs. Our teams across R&D, production, quality, and supply work together to deliver reliable API solutions for pharmaceutical companies worldwide.
To be amongst the most admired companies in APIs, Intermediaries, and Specialty Chemicals globally.
To provide top quality products in APIs, Intermediates and Specialty Chemicals through continuous innovation and cutting-edge technology, with due regards to safety and environment.
We at IOL, believe values bring character to any organization that help leaders to guide teams for a culture of excellence through continuous improvements.
IOL Chemicals and Pharmaceutical Limited was incorporated in 1986 with Acetic Acid Plant.
Commencement of Ethyl Acetate Plant
Commencement of Acetic Anhydride Plant
Commencement of Ibuprofen Unit-1
Established Unit-1 dedicated for Ibuprofen Established Multi fuel captive co-generation power plant of 4MW capacity
Commencement of Iso Butyl Benezene, Mono Chloro Acetic Acid and Acetyl Chloride Plant leading to backward integration to Ibuprofen
IOL gets listed on the National Stock Exchange (NSE) Established Multi fuel captive co-generation power plant of 13MW capacity 2012
Commencement of Unit-2 for Multi product
Received EUGMP certification
USFDA EIR for Ibuprofen
Commencement of Unit-3 for new product launches
Conversion of Unit-2 as dedicated facility for Ibuprofen
Established Unit-4 dedicated for Metformin Hydrochloride Unit-5 dedicated for Clopidogrel Bisulfate Form II & Fenofibrate
Established Unit-6 dedicated for Pantoprazole Sodium
Established Unit-7 dedicated for Metformin
Established Unit-8 for Multi Products